Trials / Completed
CompletedNCT05725252
To Evaluate the Safety and the Pharmacokinetics of NVP-2203
Phase 1 Study to Evaluate the Safety and the Pharmacokinetics of NVP-2203 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- NVP Healthcare · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and pharmacokinetics after administration of NVP-2203.
Detailed description
Phase 1 to evaluate the safety and pharmacokinetics after administration of NVP-2203.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NVP-2203 | NVP-2203(Combination of NVP-2203-R1 and NVP-2203-R2) |
| DRUG | NVP-2203-R | administration of active comparator |
Timeline
- Start date
- 2023-05-28
- Primary completion
- 2023-06-11
- Completion
- 2023-07-05
- First posted
- 2023-02-13
- Last updated
- 2024-01-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05725252. Inclusion in this directory is not an endorsement.